Skip to main content

Table 1 Characteristics of the Lewy MEMENTO groups. Prodromal dementia with Lewy bodies group (pro-DLB), group with only one core symptom (1S group), and group without any core DLB symptoms (NS group)

From: Prodromal characteristics of dementia with Lewy bodies: baseline results of the MEMENTO memory clinics nationwide cohort

 

NS group (N = 469)

1S group (N = 275)

Pro-DLB group (N = 148)

Comparisons (P-values)

Global

NS vs 1S groups*

NS vs pro-DLB groups*

1S vs pro-DLB groups*

Age, yearsa

71.4

(66.1; 77.2)

71.7

(66.0; 77.7)

71.1

(63.1; 80.5)

0.98

1.00

1.00

1.00

Gender, F/M

298/171

 

163/112

 

94/54

 

0.48

0.74

1.00

1.00

Educationb

57.4%

 

58.2%

 

47.6%

 

0.079

1.00

0.117

0.115

APOE-4, %

27.6%

 

25.6%

 

30.9%

 

0.53

1.00

1.00

0.78

CDR = 0.5, %

48.6%

 

47.6%

 

60.4%

 

0.037

1.00

0.037

0.061

MMSEa

29

(27; 30)

29

(27; 30)

28

(27; 29)

0.021

1.00

0.015

0.138

IADL (N= 8) restriction,N(%)

      

0.0031

1.00

0.0014

0.043

No

390

(84.2)

221

(81.5)

101

(70.1)

    

One

47

(10.2)

33

(12.2)

24

(16.7)

    

At least two

26

(5.6)

17

(6.3)

19

(13.2)

    

RBD

0%

 

56.7%

 

75.0%

 

NA

   

Movements during sleep

0%

 

49.8%

 

56.2%

 

NA

   

Nightmares, restless nights

0%

 

20.1%

 

45.2%

 

NA

   

Hallucinations

0%

 

13.8%

 

63.5%

 

NA

   

Passage hallucination

0%

 

3.6%

 

26.7%

 

NA

   

Presence hallucination

0%

 

4.0%

 

24.3%

 

NA

   

Visual hallucinations

0%

 

2.5%

 

17.6%

 

NA

   

Auditory hallucinations

0%

 

2.5%

 

12.8%

 

NA

   

Olfactory/taste hallucinations

0%

 

3.6%

 

12.8%

 

NA

   

Visual illusion

0%

 

2.5%

 

12.3%

 

NA

   

Delusion

0%

 

1.1%

 

12.8%

 

NA

   

Parkinsonismc

0%

 

24.4%

 

55.4%

 

NA

   

Facial expression (0/1/2/3/4)

100/0/0/0/0

 

88.8/10.9/0.4/0/0

 

62.8/31.7/3.4/2.1

 

NA

   

Rigidity

100/0/0/0/0

 

91.7/7.1/1.1/0/0

 

77.9/17.2/4.1/0.7/0

 

NA

   

Akinesia

100/0/0/0/0

 

87.2/12.8/0/0/0

 

71.0/23.4/4.1/0.7/0.7

 

NA

   

Falls

1.5%

 

3.3%

 

9.6%

 

NA

   

Fluctuations

0%

 

5.1%

 

42.6%

 

NA

   

Drowsiness/lethargy

10%

 

22.9%

 

53.4%

 

NA

   

Sleep > 2 h

0.6%

 

3.6%

 

20.3%

 

NA

   

Staring into space

0.4%

 

4.7%

 

18.4%

 

NA

   

Disorganized speech

2.1%

 

5.8%

 

32.0%

 

NA

   

Memory complainta

5

(3.0; 6.0)

5

(3.0; 7.0)

6

(4.0; 7.0)

0.0021

1.00

0.0011

0.017

Attentional complainta

4

(3.0; 6.0)

5

(3.0; 6.0)

6

(4.0; 7.0)

0.0001

0.62

< 0.0001

0.0003

FCSRT sum of 3 free recalla

30

(24.0; 35.0)

29

(24.0; 34.0)

28

(23.0; 34.0)

0.25

1.00

0.32

0.48

Fluency letter Pa

21

(16.0; 26.0)

21

(17.0; 26.0)

20

(14.0; 25.0)

0.15

1.00

0.23

0.22

Fluency animalsa

29

(23.0; 35.0)

28

(22.0; 34.0)

27

(20.0; 32.0)

0.0065

0.17

0.0093

0.49

Rey figure3min recalla

18

(11.0; 23.0)

16.5

(10.0; 21.0)

16

(10.3; 22.0)

0.128

0.21

0.49

1.00

TMT A s/good movea

1.7

(1.4; 2.3)

1.8

(1.3; 2.3)

1.9

(1.5; 2.5)

0.030

1.00

0.040

0.054

TMT B s/ good movea

3.6

(2.6; 5.0)

3.6

(2.7; 5.1)

4.2

(2.8; 5.6)

0.074

1.00

0.074

0.20

VOSP position discriminationa

20

(19.0; 20.0)

20

(19.0; 20.0)

20

(19.0; 20.0)

0.0022

1.00

0.0015

0.045

VOSP number locationa

9

(8.0; 10.0)

10

(9.0; 10.0)

9

(9.0; 10.0)

0.68

1.00

1.00

1.00

VOSP fragmented lettersa

20

(19.0; 20.0)

20

(19.0; 20.0)

20

(19.0; 20.0)

0.041

1.00

0.041

0.129

Cognitive profile,N(%)

.

 

.

 

.

 

0.0003

0.92

0.0052

0.092

SCI

125

(27.4)

69

(25.6)

28

(19.7)

    

Pure a-MCI

26

(5.7)

30

(11.1)

12

(8.5)

    

Multidomain a-MCI

135

(29.6)

83

(30.7)

55

(38.7)

    

Pure na-MCI

114

(25.0)

60

(22.2)

17

(12.0)

    

Multidomain na-MCI

56

(12.3)

28

(10.4)

30

(21.1)

    

NPI-C ≥ 1 depression,N(%)

32.5%

 

36.9%

 

49.2%

 

0.0032

0.71

0.0024

0.075

MINI 500 depression,N(%)

6.7%

 

11.1%

 

26.2%

 

< 0.0001

0.12

< 0.0001

< 0.0001

NPI-C ≥ 1 anxiety,N(%)

43.9%

 

45.8%

 

61.0%

 

0.0033

1.00

0.0029

0.018

NPI-C ≥ 1 apathy,N(%)

17.8%

 

25.1%

 

36.1%

 

< 0.0001

0.071

< 0.0001

0.086

  1. Abbreviations: a-MCI amnestic mild cognitive impairment, ATD antidepressant, ChEI cholinesterase inhibitor, CSF cerebrospinal fluid, Dopa= L-Dopa, FAB Frontal Assessment Battery, MMSE Mini-Mental Status Examination, na-MCI non-amnestic MCI, NL neuroleptics, N number, RBD rapid eye movement sleep behavior disorder, SCI subjective cognitive impairment, TMTA Trail Making Test A TMTB, Trail Making Test B, UPDRS Unified Parkinson’s Disease Rating Scale
  2. aMedian (Q1 = first quartile − Q3 = third quartile)
  3. bSchool leaving certificate; percentage
  4. cAs rated on UPDRS, out of 4
  5. *P-values for post hoc pairwise comparisons were adjusted with Bonferoni correction and then rescaled to keep an α = 0.05 statistically significant threshold for readability reason